HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Nippon India Pharma Fund - Direct (G) vs SBI Midcap Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs SBI Midcap Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

SBI Midcap Fund - Direct (G)

5.16%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Citi Bank HDFC Bank Ltd. Stock Holding Corporation of India

Computer Age Management Services Pvt. Ltd Computronics Financial Services India Ltd Datamatics Financial Software Services Ltd

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Very High Risk

5000

24126.69

1.12

274.2055

January 1, 2013

0

14.01 %

19.35 %

7.4 %

15.48 %

13.44 %

5.16 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Bhavin Vithiani

B. Com, MMS (Finance)

Mr. Bhavin Vithlani joined SBIFML in October 2018 as an Equity Research Analyst. He has over 19 years of experience in the finance sector. Prior to joining SBIFML, he was previously associated with following entities (assignments held during last 10 years): Axis Capital Limited (Erstwhile ENAM Securities Private Limited) (March 2006 - September 2018) - Primarily involved in equity research for Industrial and Power Sectors. Tower Capital & Securities Private Limited (October 2004 - March 2006) - Primarily involved in equity research for Industrial Sectors.

Sohini Andani

B.Com,CA.,

Prior to joining SBI Mutual Fund she has worked with ING Investment Management Pvt. Ltd., ASK Raymond James & Associates Pvt. Ltd., LKP Shares & securities Ltd., Advani Share Broker Pvt. Ltd., CRISIL, and K R Choksey Shares & Securities Pvt. Ltd.

Get your FAQs right